Impact of treatment with long‑acting injectable antipsychotics on hospitalization and relapse rates in schizophrenia spectrum disorders: a 3‑year follow-up mirror‑image study
Therapeutic Advances in Psychopharmacology
Published online on February 11, 2026
Abstract
Therapeutic Advances in Psychopharmacology, Volume 16, XX 2026.
Background:Long-acting injectable (LAI) antipsychotics are an important treatment option for the long-term treatment management of schizophrenia spectrum disorders (SSDs). Emerging evidences suggest a beneficial impact on long-term treatment outcomes, ...
Background:Long-acting injectable (LAI) antipsychotics are an important treatment option for the long-term treatment management of schizophrenia spectrum disorders (SSDs). Emerging evidences suggest a beneficial impact on long-term treatment outcomes, ...